Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Cancer Res. 2013 May 23;73(13):3938–3950. doi: 10.1158/0008-5472.CAN-13-0002

Figure 4. Soluble factors derived from mTNFα do not affect the rate of CD11b+ myeloid cell migration compared to control.

Figure 4

(A and B) Transwell migration assay of primary CD11b+ cells treated with conditioned media derived from LLC tumor cells transduced with control/mTNFα (A) or cotnrol/IL2spTNFα (B) constructs. Data presents the mean±SEM. (C) Representative flow cytometric analysis of CFSE-positive cells presented in LLC tumor suspension expressing either control (left) or mTNFα (right) isoform. (D) Quantification of CFSE-positive cells detected in a given number of tumor suspension (n=3 for each tumor type). Data are presented as mean±SEM, P>0.05.